pantoprazole has been researched along with Kidney Diseases in 7 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Following a single oral dose of 40 mg, Cmax is approximately 2." | 2.68 | Pharmacokinetics of pantoprazole in man. ( Bliesath, H; Hartmann, M; Huber, R; Lühmann, R; Steinijans, VW; Zech, K, 1996) |
| " If two drugs of the same class have a similar dose-efficacy profile, then the favourable/unfavourable balance of the pharmacokinetic characteristics of the drugs may determine the drug of choice." | 2.39 | Pharmacokinetics--a relevant factor for the choice of a drug? ( Benet, LZ; Zech, K, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A | 1 |
| Tam, KY | 1 |
| Schefold, JC | 1 |
| Krag, M | 1 |
| Marker, S | 1 |
| Perner, A | 1 |
| Wetterslev, J | 1 |
| Wise, MP | 1 |
| Borthwick, M | 1 |
| Bendel, S | 1 |
| Keus, F | 1 |
| Guttormsen, AB | 1 |
| Lange, T | 1 |
| Møller, MH | 1 |
| Ismail, RS | 1 |
| El-Awady, MS | 1 |
| Hassan, MH | 1 |
| Kohansal, P | 1 |
| Rajai, N | 1 |
| Dehpour, AR | 1 |
| Rashidian, A | 1 |
| Shafaroodi, H | 1 |
| Lai, B | 1 |
| Cervelli, MJ | 1 |
| Benet, LZ | 1 |
| Zech, K | 2 |
| Huber, R | 1 |
| Hartmann, M | 1 |
| Bliesath, H | 1 |
| Lühmann, R | 1 |
| Steinijans, VW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sup-Icu RENal (SIREN) - a Sub-analysis of the Prospective SUP (Stress Ulcer Prophylaxis)-ICU Trial on the Risk of GI- Bleeding in ICU Patients Receiving Renal Replacement Therapy[NCT02718261] | Phase 4 | 3,350 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pantoprazole and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics--a relevant factor for the choice of a drug?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aging; Benzimidazoles; Biological Ava | 1994 |
3 trials available for pantoprazole and Kidney Diseases
| Article | Year |
|---|---|
Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.
Topics: Acute Kidney Injury; Aged; Clostridium Infections; Critical Care; Cross Infection; Female; Gastroint | 2019 |
Effect of gastric acid suppression with pantoprazole on the efficacy of sevelamer hydrochloride as a phosphate binder in haemodialysis patients: a pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Chelating Agents; Cross-Over Studies; Dou | 2012 |
Pharmacokinetics of pantoprazole in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer A | 1996 |
3 other studies available for pantoprazole and Kidney Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |
Pantoprazole abrogated cisplatin-induced nephrotoxicity in mice via suppression of inflammation, apoptosis, and oxidative stress.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cisplatin; Cytokin | 2020 |
The protective effect of acute pantoprazole pretreatment on renal ischemia/reperfusion injury in rats.
Topics: Animals; Blood Urea Nitrogen; Blotting, Western; Creatinine; Dose-Response Relationship, Drug; Kidne | 2019 |